Expression of the epidermal growth factor system in endometrial cancer

European Journal of Gynaecological Oncology

Volumn 29, Issue 5, 2008, Pages 450-454

  Adonakis, Georgios ^a   Androutsopoulos, G ^a   Koumoundourou, D ^a   Liava, A ^a   Ravazoula, P ^a   Kourounis, G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

c erbB receptors; EGF system; Endometrial cancer; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FEMALE; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PREDICTOR VARIABLE; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT CANCER; RISK ASSESSMENT;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; TUMOR MARKERS, BIOLOGICAL;

EID: 54949122464     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jemal A., Thomas A., Murray T., Thun M.: "Cancer statistics, 2002". CA Cancer J. Clin., 2002, 52, 23.
2. Parazzini F, La Vecchia C., Bocciolone L., Francheschi S.: "The epidemiology of endometrial cancer". Gynecol. Oncol., 1991, 41, 1.
3. Alroy I., Yarden Y.: "The ErbB signalling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions". FEBS Lett., 1997, 410, 83.
4. Harris R.C., Chung E., Coffey R.J.: "EGF receptor ligands". Exp. Cell. Res., 2003, 284, 2.
5. Marmor M.D., Skaria K.B., Yarden Y.: "Signal transduction and oncogenesis by ErbB/HER receptors". Int. J. Radiat. Oncol. Biol. Phys., 2004, 58, 903.
6. Imai T., Kurachi H., Adachi K., Adachi H., Yashimoto Y., Homma H. et al.: "Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium". Biol. Reprod., 1995, 52, 928.
7. Srinivasan R., Benton E., McCormick F., Thomas H., Gullick W.J.: "Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer". Clin. Cancer Res., 1999, 5, 2877.
8. Chobotova K., Karpovich N., Carver J., Manek S., Gullick W.J., Barlow D.H. et al.: "Heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factors mediate decidualization and potentiate survival of human endometrial stromal cells". J. Clin. Endocrinol. Metab., 2005, 90, 913.
9. Ejskjaer K., Sorensen B., Poulsen S., Mogensen O., Forman A., Nexo E.: "Expression of the epidermal growth factor system in human endometrium during the menstrual cycle". Mol. Hum. Reprod., 2005, 11, 543.
10. Moller B., Rasmussen C., Lindblom B., Olovsson M.: "Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle". Mol. Hum. Reprod., 2001, 7, 65.
11. Rasheed B.K., Wiltshire R.N., Bigner S.H., Bigner D.D.: "Molecular pathogenesis of malignant gliomas". Curr. Opin. Oncol., 1999, 11, 162.
12. Schaefer G., Akita R.W., Sliwkowski M.X.: "A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2". J. Biol. Chem., 1999, 274, 859.
13. Casalini P., Iorio M.V., Gamozzi E., Menard S.: "Role of HER receptors family in development and differentiation". J. Cell. Physiol., 2004, 200, 343.
14. Wright C., Angus B., Nicholson S., Sainsbury J.R., Cairns J., Gullick W.J. et al.: "Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer". Cancer Res., 1989, 49, 2087.
15. Costa M.J., Walls J.: "Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed mullerian tumors). Clinicopathologic study of 82 cases". Cancer, 1996, 77, 533.
16. Yonemura Y., Sugiyama K., Fushida S., Kamata T., Ohoyama S., Kimura H. et al.: "Tissue status of epidermal growth factor and its receptor as an indicator of poor prognosis in patients with gastric cancer". Anal. Cell. Pathol., 1991, 3, 343.
17. Saffari B., Jones L.A., el-Naggar A., Felix J.C., George J., Press M.F.: "Amplification and overexpression of HER-2/neu (c-erbB-2) in endometrial cancers: correlation with overall survival". Canc Res., 1995, 55, 5693.
18. Pisani A.L., Barbuto D.A., Chen D., Ramos L., Lagasse L.D., Karlan B.Y.: "HER-2/neu, p53, and DNA analyses as prognosticators for survival in endometrial carcinoma". Obstet. Gynecol., 1995, 85, 729.
19. Tzahar E., Levkowitz G., Karunagaran D., Yi L., Peles E., Lavi S. et al.: "ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms". J. Biol. Chem., 1994, 269, 25226.
20. Kato T.: "Expression of mRNA for heregulin and its receptor, erbB-3 and erbB-4 in human upper gastrointestinal mucosa". Life Sc., 1998, 63, 553.
21. Kraus M.H., Issing W., Miki T., Popescu N.C., Aaronson S.A.: "Isolation and characterization of erbB-3, a third member of the ErbB/epidermal growth factor family: evidence for overexpression in a subset of human mammary tumors". Proc. Natl. Acad. Sci USA, 1989, 86, 9193.
22. Srinivasan R., Poulsom R., Hurst H.C., Gullick W.J.: "Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types". J. Pathol., 1998, 185, 236.